Capital Advisors, Ltd. LLC Seagen Inc. Transaction History

Capital Advisors, Ltd. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$127.59 - $203.08 $1,531 - $2,436	12 Added 171.43%	19 $4,000
Q4 2022 Feb 07, 2023	BUY	$117.37 - $139.17 $821 - $974	7 New	7 $1,000
Q2 2022 Aug 05, 2022	SELL	$108.81 - $179.33 $326 - $537	-3 Reduced 42.86%	4 $1,000
Q1 2022 May 09, 2022	BUY	$119.61 - $157.85 $598 - $789	5 Added 250.0%	7 $1,000
Q4 2021 Feb 08, 2022	BUY	$142.57 - $190.86 $285 - $381	2 New	2 $0

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.